Key result
Same-day discharge is feasible in ~100% of selected MitraClip patients with low bleeding risk.
Why the study?
During the COVID-19 pandemic, innovative protocols were needed to minimize hospital stays, reducing nosocomial infection risk while maintaining evidence-based care.
Does a same-day discharge protocol safely facilitate early discharge and avoid readmissions in highly selected patients undergoing transcatheter mitral valve repair with MitraClip?
Case Report (n=6)
No
Does a same-day discharge protocol safely facilitate early discharge and avoid readmissions in highly selected patients undergoing transcatheter mitral valve repair with MitraClip?
Same-day discharge after uncomplicated TMVR with MitraClip is feasible in highly selected, low-risk, independent patients, potentially improving resource utilization.
Answers are grounded in this paper and cite their sources.
May support same-day discharge feasibility in selected low-risk MitraClip patients; leaves open safety for broader use.
BACKGROUND: Due to the current Coronavirus Disease 2019 (COVID-19) pandemic, there is a realization for innovation in procedures and protocols to minimize hospital stay and at the same time ensure continued evidence-based treatment delivered to the patients. We present a same-day discharge protocol for transcatheter mitral valve repair (TMVR) using MitraClip under general anaesthesia in a six-patient case series. This protocol aims to reduce the length of hospital stay, thereby minimizing potential for nosocomial COVID-19 infections and to promote safe discharge with cautious follow-up. CASE SUMMARY: Six patients with severe symptomatic mitral valve (MV) regurgitation underwent successful transfemoral MV repair using standard procedures. Following repair, patients were monitored on telemetry in the recovery area for 3 h, ambulated to assess vascular access stability and underwent post-procedural transthoracic echocardiogram to assess for any pericardial effusion or post-procedural prosthetic mitral stenosis. CONCLUSION: Same-day discharge after TMVR is possible when done cautiously with close follow-up, can minimize hospital stay, improve resource utilization, and reduce risk of nosocomial COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Chowdhury et al. (2021) conducted a case report in Severe symptomatic mitral valve regurgitation (n=6). Transcatheter mitral valve repair (TMVR) using MitraClip with same-day discharge protocol was evaluated on Successful same-day discharge without early complications preventing discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: